Question Period Notes
About this information
In accordance with the Access to Information Act, the government proactively publishes the package of question period notes that were prepared by a government institution for the minister and that were in use on the last sitting day in June and December.
The question period notes may be partially or fully redacted in accordance with the legislation; for example, if the notes contain information related to national security or personal information. (Learn more about exemptions and exclusions.)
If you find a question period note of interest, you may make an access to information request in order to obtain it.
• What is Health Canada doing to help Canadians get access to treatments for COVID-19?
• Given recent reports of blood clots following the use of viral vector COVID-19 vaccines (COVISHIELD, AstraZeneca, Janssen) in Canada and internationally, and international reports of myocarditis after mRNA vaccination, What is the Government doing to ensure vaccine safety, including monitoring for adverse reactions to the COVID-19 vaccines?
• How is the Government making its decisions on the safe use of viral vector and mRNA vaccines?
• What is the current status of the AstraZeneca, COVISHIELD and Janssen vaccines in Canada?
• What are NACI’s updated recommendations on COVID-19 vaccines?
• What is Health Canada doing to ensure that vaccines coming from the Emergent site are safe?
• What is the government doing to make sure the provinces and territories have the vaccines they need?
• What is the current status of COVID-19 vaccines expected to be available for Canadians?
• Given recent reports of blood clots following the use of viral vector COVID-19 vaccines (COVISHIELD, AstraZeneca, Janssen) in Canada and internationally, and international reports of myocarditis after mRNA vaccination, What is the Government doing to ensure vaccine safety, including monitoring for adverse reactions to the COVID-19 vaccines?
• How is the Government making its decisions on the safe use of viral vector and mRNA vaccines?
How will the Vaccine Injury Support Program (VISP) support Canadians who experience a serious and permanent injury as a result of receiving a Health Canada authorized vaccine?
• What is the Government doing to ensure vaccine supply and to inoculate all Canadians?